COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Urinary Incontinence Devices Market would witness market growth of 11.2% CAGR during the forecast period (2017 – 2023).
Urinary incontinence is an unintentional leakage of urine, and it is differentiated into four types, namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Urinary incontinence is most commonly found in women.
Europe is the region with tremendous market potential and would grow at a notable rate during the forecast period. The growth is primarily attributed to the product innovation in Urinary Incontinence Devices, growing cases of urinary incontinence, recent launch of wearable electrical stimulation devices, and high per capita health care expenditure in the region.

Based on product, the market report segments the market into Vaginal Slings, Urinary Catheters, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Other Devices. The category segment includes External Urinary Incontinence Devices and Internal Urinary Incontinence Devices. The Incontinence Type segment covers Stress Incontinence, Urge Incontinence, Overflow Incontinence, and Functional Incontinence. Based on countries, the Urinary Incontinence Devices market segments the market into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the Europe Urinary Incontinence Devices Market. Key companies profiled in the report include C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, Zephyr Surgical Implants, and Incontrol Medical LLC.